216 related articles for article (PubMed ID: 24631531)
1. MicroRNA-363-mediated downregulation of S1PR1 suppresses the proliferation of hepatocellular carcinoma cells.
Zhou P; Huang G; Zhao Y; Zhong D; Xu Z; Zeng Y; Zhang Y; Li S; He F
Cell Signal; 2014 Jun; 26(6):1347-54. PubMed ID: 24631531
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.
Lu Y; Yue X; Cui Y; Zhang J; Wang K
Biochem Biophys Res Commun; 2013 Nov; 441(4):873-9. PubMed ID: 24211205
[TBL] [Abstract][Full Text] [Related]
3. miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.
Zhang Y; Zheng D; Xiong Y; Xue C; Chen G; Yan B; Ye Q
FEBS Lett; 2014 May; 588(10):1913-20. PubMed ID: 24704686
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X
Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells.
Yang Y; Li M; Chang S; Wang L; Song T; Gao L; Hu L; Li Z; Liu L; Yao J; Huang C
Mol Med Rep; 2014 Nov; 10(5):2643-8. PubMed ID: 25174704
[TBL] [Abstract][Full Text] [Related]
7. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
El Tayebi HM; Hosny KA; Esmat G; Breuhahn K; Abdelaziz AI
FEBS Lett; 2012 Sep; 586(19):3309-16. PubMed ID: 22819824
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-7 upregulates Cullin 5 (CUL5) to facilitate G1/S transition in human hepatocellular carcinoma cells.
Ma C; Qi Y; Shao L; Liu M; Li X; Tang H
IUBMB Life; 2013 Dec; 65(12):1026-34. PubMed ID: 24339204
[TBL] [Abstract][Full Text] [Related]
9. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
13. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
Gu W; Li X; Wang J
Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.
Tan W; Lim SG; Tan TM
World J Gastroenterol; 2015 Dec; 21(46):13030-41. PubMed ID: 26676187
[TBL] [Abstract][Full Text] [Related]
15. MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients.
Yuan B; Liang Y; Wang D; Luo F
Cancer Sci; 2015 Jul; 106(7):819-24. PubMed ID: 25940592
[TBL] [Abstract][Full Text] [Related]
16. Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling.
Zhang JF; He ML; Fu WM; Wang H; Chen LZ; Zhu X; Chen Y; Xie D; Lai P; Chen G; Lu G; Lin MC; Kung HF
Hepatology; 2011 Dec; 54(6):2137-48. PubMed ID: 21809363
[TBL] [Abstract][Full Text] [Related]
17. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines.
Lin CJ; Gong HY; Tseng HC; Wang WL; Wu JL
Biochem Biophys Res Commun; 2008 Oct; 375(3):315-20. PubMed ID: 18692484
[TBL] [Abstract][Full Text] [Related]
18. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.
Xu J; Zhu X; Wu L; Yang R; Yang Z; Wang Q; Wu F
Liver Int; 2012 May; 32(5):752-60. PubMed ID: 22276989
[TBL] [Abstract][Full Text] [Related]
20. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
Zhao L; Zhang Y
Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]